These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 15907526)

  • 21. Evaluation of treatment with direct thrombin inhibitors in patients with heparin-induced thrombocytopenia.
    Dang CH; Durkalski VL; Nappi JM
    Pharmacotherapy; 2006 Apr; 26(4):461-8. PubMed ID: 16553503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Argatroban therapy does not generate antibodies that alter its anticoagulant activity in patients with heparin-induced thrombocytopenia.
    Walenga JM; Ahmad S; Hoppensteadt D; Iqbal O; Hursting MJ; Lewis BE
    Thromb Res; 2002 Mar; 105(5):401-5. PubMed ID: 12062541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Weight-based argatroban dosing nomogram for treatment of heparin-induced thrombocytopenia.
    Ansara AJ; Arif S; Warhurst RD
    Ann Pharmacother; 2009 Jan; 43(1):9-18. PubMed ID: 19126826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of pulmonary embolism with argatroban and ultrasound-assisted catheter-directed thrombolysis with alteplase in a patient with heparin-induced thrombocytopenia.
    Bethea BT; Elliot JW; Richardson JB; Ahmed MI
    Am J Health Syst Pharm; 2017 Aug; 74(15):1153-1157. PubMed ID: 28743779
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antithrombotic drugs for the treatment of heparin-induced thrombocytopenia.
    Jeske WP; Walenga JM
    Curr Opin Investig Drugs; 2002 Aug; 3(8):1171-80. PubMed ID: 12211410
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced argatroban doses after coronary artery bypass graft surgery.
    Hoffman WD; Czyz Y; McCollum DA; Hursting MJ
    Ann Pharmacother; 2008 Mar; 42(3):309-16. PubMed ID: 18303137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Argatroban therapy in women with heparin-induced thrombocytopenia.
    Jang IK; Baron SJ; Hursting MJ; Anglade E
    J Womens Health (Larchmt); 2007; 16(6):895-901. PubMed ID: 17678460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and economic considerations of argatroban use in critically ill patients: a retrospective analysis.
    Kim SC; Tran N; Schewe JC; Boehm O; Wittmann M; Graeff I; Hoeft A; Baumgarten G
    J Cardiothorac Surg; 2015 Feb; 10():19. PubMed ID: 25879883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Argatroban: a review of its use in the management of heparin-induced thrombocytopenia.
    Dhillon S
    Am J Cardiovasc Drugs; 2009; 9(4):261-82. PubMed ID: 19655821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Argatroban in HIT type II and acute coronary syndrome.
    Lewis BE; Walenga JM
    Pathophysiol Haemost Thromb; 2002; 32 Suppl 3():46-55. PubMed ID: 12811012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Argatroban for suspected heparin-induced thrombocytopenia: contemporary experience at a large teaching hospital.
    Kodityal S; Nguyen PH; Kodityal A; Sherer J; Hursting MJ; Rice L
    J Intensive Care Med; 2006; 21(2):86-92. PubMed ID: 16537750
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Argatroban anticoagulation in intensive care patients: effects of heart failure and multiple organ system failure.
    Begelman SM; Baghdasarian SB; Singh IM; Militello MA; Hursting MJ; Bartholomew JR
    J Intensive Care Med; 2008; 23(5):313-20. PubMed ID: 18701526
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transitioning from argatroban to warfarin therapy in patients with heparin-induced thrombocytopenia.
    Hursting MJ; Lewis BE; Macfarlane DE
    Clin Appl Thromb Hemost; 2005 Jul; 11(3):279-87. PubMed ID: 16015413
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Argatroban in the management of heparin-induced thrombocytopenia.
    Babuin L; Pengo V
    Vasc Health Risk Manag; 2010 Sep; 6():813-9. PubMed ID: 20859550
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Argatroban in extracorporeal membrane oxygenation.
    Beiderlinden M; Treschan T; Görlinger K; Peters J
    Artif Organs; 2007 Jun; 31(6):461-5. PubMed ID: 17537058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Argatroban for prevention and treatment of thromboembolism in heparin-induced thrombocytopenia.
    Kondo LM; Wittkowsky AK; Wiggins BS
    Ann Pharmacother; 2001 Apr; 35(4):440-51. PubMed ID: 11302409
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Argatroban use during pediatric interventional cardiac catheterization.
    Cetta F; Graham LC; Wrona LL; Arruda MJ; Walenga JM
    Catheter Cardiovasc Interv; 2004 Jan; 61(1):147-9. PubMed ID: 14696176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heparin-induced thrombocytopenia from venous thromboembolism treatment.
    Begelman SM; Hursting MJ; Aghababian RV; McCollum D
    J Intern Med; 2005 Dec; 258(6):563-72. PubMed ID: 16313480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Excessive argatroban anticoagulation for heparin-induced thrombocytopenia.
    Reichert MG; MacGregor DA; Kincaid EH; Dolinski SY
    Ann Pharmacother; 2003 May; 37(5):652-4. PubMed ID: 12708939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A case of heparin-induced thrombocytopenia associated with unexpected excessive argatroban anticoagulation after abdominal aortic aneurysm resection].
    Ichikawa M; Oue M; Okamoto A; Morishita H; Minatoya K; Ogino H; Miyata S; Imanaka H
    Masui; 2006 Feb; 55(2):188-92. PubMed ID: 16491897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.